Business Context and Reporting Period
Company: Pavmed Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 10, 2020 (Event Date); January 13, 2020 (Signature Date)
Reporting Period: Specific event regarding Nasdaq listing compliance status.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
Nasdaq Listing Compliance:
- Previous Status: On October 10, 2019, Nasdaq notified the Company that its common stock closing bid price had been below the $1.00 minimum requirement for 30 consecutive business days.
- Compliance Period: The Company was granted 180 calendar days to regain compliance, requiring a closing bid price of at least $1.00 for 10 consecutive business days.
- Current Status: Nasdaq confirmed that from December 26, 2019, to January 9, 2020, the closing bid price met the $1.00 threshold. The Company has officially regained compliance with Nasdaq Listing Rule 5550(a)(2).
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on January 13, 2020, confirming the regained compliance status.
Risks and Contingencies: The filing addresses the resolution of a delisting risk associated with low stock price. No new risks, guidance, or unusual items are disclosed in this specific report.
Investor Verification Checklist
- Verify the current trading price of PAVM to ensure it remains above the $1.00 minimum bid price requirement.
- Review the attached press release (Exhibit 99.1) for any additional operational updates not detailed in the 8-K text.
- Monitor future filings for any recurrence of low bid price notifications from Nasdaq.